Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.15
-0.02 (-0.39%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Intensity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 13 | 25 | 27 | 117 | - | - | |
| Market Cap Growth | -55.40% | -7.32% | -77.37% | - | - | - | |
| Enterprise Value | 2 | 18 | 24 | 102 | - | - | |
| Last Close Price | 5.23 | 10.26 | 44.00 | 214.25 | - | - | |
| PB Ratio | 1.11 | 2.08 | 9.11 | 8.93 | - | - | |
| P/TBV Ratio | 1.12 | 2.08 | 9.11 | 8.93 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.05 | 0.01 | -0.88 | 1.78 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.84 | -1.11 | -0.62 | -1.67 | |
| Quick Ratio | 5.56 | 5.56 | 1.48 | 3.73 | 0.19 | 1.23 | |
| Current Ratio | 5.92 | 5.92 | 1.92 | 3.91 | 0.21 | 1.27 | |
| Return on Equity (ROE) | -156.90% | -156.90% | -202.34% | -261.36% | - | -161.84% | |
| Return on Assets (ROA) | -79.25% | -79.25% | -93.90% | -54.58% | -135.34% | -65.19% | |
| Return on Capital Employed (ROCE) | -100.10% | -100.10% | -547.70% | -62.40% | 149.20% | -535.90% | |
| Earnings Yield | -87.18% | -47.11% | -61.19% | -8.97% | - | - | |
| Buyback Yield / Dilution | -143.83% | -143.83% | -61.40% | -152.67% | - | -0.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.